References
- Bridges JW, French MR, Smith RL, Williams RT. (1970). The fate of benzoic acid in various species. Biochem J 118:47–51.
- Kanazu T, Yamaguchi. T. (1997). Comparison of in vitro carnitine and glycine conjugation with branched side-chain and cyclic side-chain carboxylic acids in rats. Drug Metab Disposit 25:149–53.
- Kao J, Jones CA, Fry JR, Bridges JW. (1978). Species differences in the metabolism of benzoic acid by isolated hepatocytes and kidney tubule fragments. Life Sc 23:1221–8.
- Millington DS, Bohman TP, Roe CR, Yergey AL, Liberator DJ. (1985). Valproylcarnitine: a noble drug metabolite identified by fast bombardment and thermospray liquid chromatography-mass spectrometry. Clinica Chimica Acta 145:69–76.
- Mizojiri K, Futaguch S, Norikura R, Katsuyama Y, Nagasak T, Yoshimori T, Nakanishi M. (1995). Disposition of S-1108, a new oral cephem antibiotic, and metabolic fate of pivalic acid liberated from [pivaloyl-14C]S-1108 in rats and dogs. Antimicrob Agent Chemother 39:1445–53.
- Moldeus P, Hoegberg J, Orrenius S. (1978). Isolation and use of liver cells. In: Fleischer S, Packer L. eds. Methods in enzymology, Vol. 52. New York, NY: Academic Press, 60–71.
- Nishibe Y, Hirata M. (1993). Effect of phenobarbital and other model inducers on cytochrome P450 isoenzymes in primary culture of dog hepatocytes. Xenobiotica 23:681–92.
- Nishibe Y, Hirata M. (1995). Inducers on cytochrome P-450 isoenzymes in cultured monkey hepatocytes. Int J Biochem Cell Biol 27:279–85.
- Ohashi R, Tamai I, Yabuuchi H, Nezu J, Oku A, Sai Y, Shimane M, Tsuji A. (1999). Na+-dependent carnitine transport by organic cation transporter (OCTN2): Its pharmacological and toxicological relevance. J Pharmacol Exp Ther 29:778–84.
- Okamura N, Ohnishi S, Shimaoka H, Norikura R, Hasegawa H. (2006). Involvement of recognition and interaction of carnitine transporter in the decrease of L-carnitine concentration induced by pivalic acid and valproic acid. Pharmaceut Res 23:1729–35.
- Powis G, Melder DC, Wilke TJ. (1989). Human and dog, but not rat, isolated hepatocytes have decreased foreign compound-metabolizing activity compared to liver slices. Drug Metab Disposit 17:526–31.
- Quistad GB, Staiger LE, Scooley DA. (1978a). Environmental degradation of the miticide cycloprate (hexadecyl cyclopropanecarboxylate). 1. Rat metabolism. J Agricult Food Chem 26:60–6.
- Quistad GB, Staiger LE, Scooley DA. (1978b). Environmental degradation of the miticide cycloprate (hexadecyl cyclopropanecarboxylate). 3. Bovine metabolism. J Agricult Food Chem 26:71–5.
- Quistad GB, Staiger LE, Scooley DA. (1978c). Environmental degradation of the miticide cycloprate (hexadecyl cyclopropanecarboxylate). 4. Beagle dog metabolism. J Agricult Food Chem 26:76–80.
- Totsuka K, Shimizu K, Konishi M, Yamamoto S. (1992). Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans. Antimicrob Agent Chemotherap 36:757–61.
- Yamashita A, Watanabe M, Tonegawa T, Sugimura T, Waku K. (1995). Acyl-CoA binding and acylation of UDP-glucuronosyltransferase isoforms of rat liver: their effect on enzyme activity. Biochem J 312:301–8.